RAMELLA, SARA
 Distribuzione geografica
Continente #
AS - Asia 11.409
NA - Nord America 3.429
EU - Europa 2.121
SA - Sud America 550
AF - Africa 85
OC - Oceania 16
Totale 17.610
Nazione #
SG - Singapore 8.975
US - Stati Uniti d'America 3.258
CN - Cina 1.121
IT - Italia 1.113
HK - Hong Kong 593
BR - Brasile 393
VN - Vietnam 261
GB - Regno Unito 224
FR - Francia 218
DE - Germania 181
BD - Bangladesh 125
IN - India 96
NL - Olanda 96
CA - Canada 81
EE - Estonia 57
AR - Argentina 56
FI - Finlandia 49
ID - Indonesia 46
MX - Messico 42
ZA - Sudafrica 31
EC - Ecuador 29
TR - Turchia 28
IQ - Iraq 25
SE - Svezia 20
UA - Ucraina 20
CO - Colombia 19
ES - Italia 18
JP - Giappone 18
AT - Austria 17
CZ - Repubblica Ceca 16
CL - Cile 15
RU - Federazione Russa 15
PH - Filippine 14
PL - Polonia 14
SA - Arabia Saudita 14
AU - Australia 13
PE - Perù 12
PK - Pakistan 12
MD - Moldavia 11
TN - Tunisia 10
VE - Venezuela 10
MA - Marocco 9
RO - Romania 9
KZ - Kazakistan 8
UZ - Uzbekistan 8
CR - Costa Rica 7
EG - Egitto 7
JM - Giamaica 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
KE - Kenya 6
LT - Lituania 6
NI - Nicaragua 6
NP - Nepal 6
UY - Uruguay 6
BO - Bolivia 5
CH - Svizzera 5
HU - Ungheria 5
MY - Malesia 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
OM - Oman 4
PY - Paraguay 4
BE - Belgio 3
BG - Bulgaria 3
GE - Georgia 3
IE - Irlanda 3
PA - Panama 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HT - Haiti 2
IR - Iran 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
Totale 17.582
Città #
San Jose 1.240
Singapore 771
Rome 669
Ashburn 604
Hong Kong 524
Hefei 394
Beijing 267
Dallas 223
Boardman 197
Lauterbourg 191
London 174
Shanghai 138
Munich 104
Ho Chi Minh City 98
New York 97
Council Bluffs 85
Los Angeles 72
Hanoi 58
Santa Clara 55
Amsterdam 43
San Francisco 38
Naples 32
São Paulo 30
Turku 28
Milan 27
Pune 27
Seattle 26
Washington 26
Toronto 24
Chicago 21
Helsinki 21
Mexico City 18
Brooklyn 17
Montreal 15
Chennai 14
Atlanta 13
Las Vegas 13
Orem 13
Quito 13
Boston 12
Brno 12
Charlotte 12
Haiphong 12
Johannesburg 12
Rio de Janeiro 12
Sona 11
Tokyo 11
Buffalo 10
Florence 10
Frankfurt am Main 10
Lima 10
Nuremberg 10
Palermo 10
Phoenix 10
St Louis 10
Stockholm 10
Warsaw 10
West Jordan 10
Bogotá 9
Jakarta 9
Biên Hòa 8
Bologna 8
Curitiba 8
Da Nang 8
Guangzhou 8
Guayaquil 8
Hải Dương 8
Manaus 8
Manchester 8
Tashkent 8
Baghdad 7
Brasília 7
Buenos Aires 7
Dhaka 7
San José 7
Ankara 6
Bari 6
Belo Horizonte 6
Denver 6
Guarulhos 6
Hangzhou 6
Hanover 6
Managua 6
Nairobi 6
New Delhi 6
Redmond 6
Santiago 6
Dammam 5
Guatemala City 5
Jinan 5
Marseille 5
Melbourne 5
Montevideo 5
Rocca di Papa 5
Salvador 5
Santo André 5
Vicenza 5
Amman 4
Bangkok 4
Bergamo 4
Totale 6.891
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 341
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 328
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 276
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 252
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 251
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 242
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 236
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 229
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 228
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 227
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 227
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 225
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 221
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 220
Exploring Deep Pathomics in Lung Cancer 219
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 219
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 218
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 216
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 216
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 214
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 213
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 213
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 213
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 212
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 208
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 208
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 205
Preventing Cardiotoxicity in Personalized Breast Irradiation 201
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 199
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 196
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 191
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 187
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 163
A deep learning approach for overall survival prediction in lung cancer with missing values 158
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 157
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 153
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 140
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 138
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 135
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 131
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 130
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 130
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 130
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 127
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 127
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 127
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 126
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 125
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 125
Evaluating GANs in Medical Imaging 124
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 123
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 120
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 120
MR imaging of rectal cancer before and after chemoradiation therapy 120
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 118
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 118
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 117
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 113
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 112
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 111
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 110
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 109
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 108
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 106
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 105
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 104
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 104
Chemoradiation for stage III non-small cell lung cancer 103
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 100
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 92
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 91
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 86
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 81
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 80
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 73
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort 66
Precision radiotherapy by SPECT lung functional imaging in NSCLC 65
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 61
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 60
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 59
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study 58
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis 58
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 56
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 56
Protective Role of Natural Compounds under Radiation-Induced Injury 56
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 56
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 55
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 55
Radiation therapy of breast cancer. Reasoned approach to a clinical case 55
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 53
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 52
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 52
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 51
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 50
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. 50
Locally advanced NSCLC: how to improve disease control? 50
Stage III NSCLC treatment options: too many choices 49
The first survey on defensive medicine in radiation oncology 49
Dose fractionation and biological optimization in lung cancer 48
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 48
Totale 13.689
Categoria #
all - tutte 91.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 6 6 5 1 3 6 6 13 7 0 167
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024590 21 62 36 35 60 250 14 35 4 22 11 40
2024/20259.985 95 48 220 64 111 218 153 34 520 723 3.590 4.209
2025/20266.768 612 324 483 740 294 400 1.803 474 560 586 290 202
Totale 17.735